MARKET

ENZ

ENZ

Enzo Biochem Inc
NYSE
1.850
+0.070
+3.93%
Pre Market: 1.800 -0.05 -2.70% 09:15 12/08 EST
OPEN
1.760
PREV CLOSE
1.780
HIGH
1.870
LOW
1.760
VOLUME
18
TURNOVER
0
52 WEEK HIGH
3.700
52 WEEK LOW
1.740
MARKET CAP
90.13M
P/E (TTM)
-4.9294
1D
5D
1M
3M
1Y
5Y
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report first quarter fiscal 2023 ...
GlobeNewswire · 19h ago
As Enzo Biochem, Inc. (NYSE:ENZ) drops to US$100m market cap, insiders might rethink their US$3.1m stock purchase earlier this year
The recent 13% drop in Enzo Biochem, Inc.'s ( NYSE:ENZ ) stock could come as a blow to insiders who purchased US$3.1m...
Simply Wall St. · 11/18 14:31
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders’ Meeting will be held on January 31, 2023. Shareholders mu...
GlobeNewswire · 11/08 23:04
BRIEF-Farmer Bros Announces Board Refresh And Cooperation Agreement With Stockholders JCP Investment Management and 22NW
Reuters · 10/31 12:39
Enzo Biochem appoints Patricia Eckert as interim CFO
Seekingalpha · 10/20 12:27
The past five years for Enzo Biochem (NYSE:ENZ) investors has not been profitable
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...
Simply Wall St. · 10/17 12:51
BRIEF-Enzo Biochem Reports Qtrly Loss Of $0.17 Per Share
Reuters · 10/14 11:48
Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M
Seekingalpha · 10/14 11:36
More
About ENZ
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab and life sciences company. The Company is focused on delivering and applying advanced technology capabilities to produce products and services that enable its customers to meet their clinical needs. The Company operates through three segments. Enzo Clinical Lab segment is a clinical reference laboratory, which provides a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Life Sciences has developed products used in the identification of genomic information by laboratories around the world. Enzo Therapeutics is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.

Webull offers kinds of Enzo Biochem Inc stock information, including NYSE:ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.